# EXtension of Tablo TrEatmeNt Duration Registry

> **NCT04912050** · — · COMPLETED · sponsor: **Outset Medical** · enrollment: 33 (actual)

## Conditions studied

- End Stage Renal Disease (ESRD)
- End Stage Renal Disease on Dialysis
- Acute Kidney Injury

## Interventions

- **DEVICE:** Tablo Hemodialysis System

## Key facts

- **NCT ID:** NCT04912050
- **Lead sponsor:** Outset Medical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-25
- **Primary completion:** 2022-05-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2022-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04912050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04912050, "EXtension of Tablo TrEatmeNt Duration Registry". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT04912050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*